Pathogenic variants inPIK3CAare associated with clinical phenotypes of kaposiform lymphangiomatosis, generalized lymphatic anomaly, and central conducting lymphatic anomaly

Author:

Grenier Jeremy M.1ORCID,Borst Alexandra J.2ORCID,Sheppard Sarah E.3,Snyder Kristen M.12ORCID,Li Dong4,Surrey Lea F.5,Al‐Ibraheemi Alyaa6,Weber David R.2,Treat James R.2,Smith Christopher L.2,Laje Pablo2,Dori Yoav2,Adams Denise M.12,Acord Michael7,Srinivasan Abhay S.27ORCID

Affiliation:

1. Division of Oncology Children's Hospital of Philadelphia Philadelphia Pennsylvania USA

2. Comprehensive Vascular Anomaly Program Children's Hospital of Philadelphia Philadelphia Pennsylvania USA

3. Unit on Vascular Malformations Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development Bethesda Maryland USA

4. Center for Applied Genomics Children's Hospital of Philadelphia Philadelphia Pennsylvania USA

5. Department of Pathology and Laboratory Medicine Children's Hospital of Philadelphia Philadelphia Pennsylvania USA

6. Department of Pathology Boston Children's Hospital Boston Massachusetts USA

7. Division of Interventional Radiology Children's Hospital of Philadelphia Philadelphia Pennsylvania USA

Abstract

AbstractComplex lymphatic anomalies are debilitating conditions characterized by aberrant development of the lymphatic vasculature (lymphangiogenesis). Diagnosis is typically made by history, examination, radiology, and histologic findings. However, there is significant overlap between conditions, making accurate diagnosis difficult. Recently, genetic analysis has been offered as an additional diagnostic modality. Here, we describe four cases of complex lymphatic anomalies, all withPIK3CAvariants but with varying clinical phenotypes. Identification ofPIK3CAresulted in transition to a targeted inhibitor, alpelisib. These cases highlight the genetic overlap between phenotypically diverse lymphatic anomalies.

Funder

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Institutes of Health

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3